| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| pmid30124346-compound-ldt8 | adrenergic receptor alpha-1a | NA | Successful target | TTD , DGIDB | Benign Prostatic Hyperplasia[MeSHID:D011470] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | patented | unknown |
| pmid30124346-compound-ldt8 | adrenergic receptor alpha-1d | NA | Successful target | TTD , DGIDB | Benign Prostatic Hyperplasia[MeSHID:D011470] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | patented | unknown |
| pmid30124346-compound-ldt8 | 5-ht 1a receptor | NA | Successful target | TTD , DGIDB | Benign Prostatic Hyperplasia[MeSHID:D011470] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | patented | unknown |
| pmid30124346-compound-ldt8 | 5-ht 2a receptor | NA | Successful target | TTD , DGIDB | Benign Prostatic Hyperplasia[MeSHID:D011470] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | patented | unknown |
| click here to return to the previous page | ||||||||